sing a tracker incorporated into Budesonide/Formoterol turbuhaler to improve asthma control: a randomized controlled study
Not Applicable
Recruiting
- Conditions
- Patients with moderate to severe asthma with/without turbuhaler-incorporated tracker to assist asthma control
- Registration Number
- JPRN-UMIN000042690
- Lead Sponsor
- Taipei Veterans General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who meet any one of the following criteria will be excluded: 1. Hypersensitivity to BUD/FOR. 2. Had lower respiratory tract infections or received systemic steroid 4 weeks before enrollment. 3. Smoking history greater than 20 pack-years. 4. The onset of respiratory symptoms after the age of 40 years in current or previous smokers with a smoking history greater than 10 pack-years. 5. COPD, clinically overt bronchiectasis, lung cancer, active tuberculosis, or other known specific pulmonary disease. 6. A chest X-ray indicating diagnosis other than asthma that might interfere with the study. 7. Alcohol or medication abuse. 8. Pregnant woman. 9. Unable or unwilling to sign permit.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Treatment difference (post- minus pre-treatment) of FeNO between the tracker and usual care groups
- Secondary Outcome Measures
Name Time Method Any one of the following conditions are estimated and regarded as secondary objectives: Changes from baseline on ACT score, FeNO, lung function, blood parameters within the same group; Treatment difference (post- minus pre-treatment) on ACT, lung function, blood parameters between the 2 groups; Electronic record of numbers and patterns of inhaler use; Correlation between inhaler use and asthma outcomes (symptoms worsening, any exacerbation, severe exacerbation); Annualized rate of severe exacerbations